Lung Cancer News

American Society for Radiation Oncology chose Corey J. Langer, MD, as its 2019 honorary member.

Many facilities exceed recommended radiation doses for lung cancer screening CT scans. However, institutions following protocols set by a lead radiologist or internal medical physicist had lower doses, according to a study published in JAMA Internal Medicine.

BARCELONA, Spain — Osimertinib significantly extended OS compared with standard epidermal growth factor receptor tyrosine kinase inhibitors as front-line treatment for EGFR-mutated advanced non-small cell lung cancer, according to late-breaking results of the randomized phase 3 FLAURA study presented at European Society for Medical Oncology Congress.

BARCELONA, Spain — A combination of nivolumab and low-dose ipilimumab significantly improved OS compared with chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer, according to results of the randomized phase 3 CheckMate 227 study presented at European Society for Medical Oncology Congress.

BARCELONA, Spain — Atezolizumab significantly prolonged OS compared with platinum-based chemotherapy for patients with newly diagnosed non-small cell lung cancer whose tumors expressed high levels of PD-L1, according to an interim survival analysis from the phase 3 IMpower110 study presented at European Society for Medical Oncology Congress.

Today marks World Lung Day, and this year’s theme is “healthy lungs for all.”

More than half of World Trade Center responders with available CT scans had evidence of pulmonary nodules, a recent study shows.

Durvalumab extended the time to first progression and reduced the risk for local and distant progression among patients with unresectable stage III non-small cell lung cancer, according to an exploratory analysis of the phase 3 PACIFIC trial presented at American Society for Radiation Oncology Annual Meeting.

Charles Rudin, MD, PhD, received the Paul A. Bunn Jr. Scientific Award from International Association for the Study of Lung Cancer.

Denise Aberle, MD, received International Association for the Study of Lung Cancer’s Joseph W. Cullen Prevention/Early Detection Award.